FendX Appoints Dr. Rohit Ramchandani, an Accomplished Public Health Expert, as Advisor
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) has appointed Dr. Rohit Ramchandani as an advisor to leverage his extensive public health expertise in advancing innovative solutions for pathogen control and safety. Dr. Ramchandani, a global expert in public health and infectious disease control, brings nearly two decades of experience in designing, implementing, and scaling innovative approaches for disease control and health system strengthening.
His role at FendX will be to inform, advise, and support the company's mission to develop surface protection coatings that reduce pathogen spread. Dr. Ramchandani's expertise, particularly in pandemic response and antibiotic resistance, aligns with FendX's goal of addressing growing public health threats. His appointment is expected to contribute significantly to FendX's efforts in creating groundbreaking solutions for mitigating pathogen transmission and improving overall well-being.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) ha nominato Dr. Rohit Ramchandani come consulente per sfruttare la sua vasta esperienza nella salute pubblica per promuovere soluzioni innovative per il controllo dei patogeni e la sicurezza. Il Dr. Ramchandani, esperto mondiale in salute pubblica e controllo delle malattie infettive, porta con sé quasi due decenni di esperienza nella progettazione, implementazione e scalabilità di approcci innovativi per il controllo delle malattie e il potenziamento dei sistemi sanitari.
Il suo ruolo in FendX sarà quello di informare, consigliare e supportare la missione dell'azienda di sviluppare rivestimenti protettivi per superfici che riducano la diffusione dei patogeni. L'expertise del Dr. Ramchandani, in particolare nella risposta alle pandemie e nella resistenza agli antibiotici, si allinea con l'obiettivo di FendX di affrontare le crescenti minacce per la salute pubblica. Si prevede che la sua nomina contribuisca in modo significativo agli sforzi di FendX nella creazione di soluzioni innovative per ridurre la trasmissione dei patogeni e migliorare il benessere generale.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) ha nombrado al Dr. Rohit Ramchandani como asesor para aprovechar su amplia experiencia en salud pública y avanzar en soluciones innovadoras para el control de patógenos y la seguridad. El Dr. Ramchandani, experto global en salud pública y control de enfermedades infecciosas, aporta casi dos décadas de experiencia en el diseño, implementación y escalado de enfoques innovadores para el control de enfermedades y el fortalecimiento de los sistemas de salud.
Su función en FendX consistirá en informar, asesorar y apoyar la misión de la empresa de desarrollar recubrimientos protectores para superficies que reduzcan la propagación de patógenos. La experiencia del Dr. Ramchandani, particularmente en la respuesta a pandemias y resistencia a antibióticos, está en línea con el objetivo de FendX de abordar las crecientes amenazas a la salud pública. Se espera que su nombramiento contribuya de manera significativa a los esfuerzos de FendX para crear soluciones innovadoras que mitiguen la transmisión de patógenos y mejoren el bienestar general.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)는 Dr. Rohit Ramchandani를 고문으로 임명하여 그의 광범위한 공공 건강 전문 지식을 활용하려고 합니다. Dr. Ramchandani는 공공 건강 및 전염병 통제의 세계적 전문가로서, 질병 통제 및 건강 시스템 강화를 위한 혁신적인 접근 방식을 설계하고 구현하고 확장하는 데 거의 20년의 경험을 가지고 있습니다.
FendX에서 그의 역할은 회사를 지원하고, 조언하며, 표면 보호 코팅 개발의 임무를 알리는 것입니다. Dr. Ramchandani의 전문성, 특히 팬데믹 대응 및 항생제 내성 분야는 FendX의 공공 건강 위협 해결 목표와 일치합니다. 그의 임명은 병원체 전파 완화 및 전반적인 웰빙 향상에 대한 FendX의 노력에 크게 기여할 것으로 예상됩니다.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) a nommé Dr. Rohit Ramchandani comme conseiller pour tirer parti de son expertise étendue en santé publique afin de faire avancer des solutions innovantes pour le contrôle des agents pathogènes et la sécurité. Dr. Ramchandani, expert mondial en santé publique et en contrôle des maladies infectieuses, apporte près de deux décennies d'expérience dans la conception, la mise en œuvre et l'échelle d'approches innovantes pour le contrôle des maladies et le renforcement des systèmes de santé.
Son rôle chez FendX consistera à informer, conseiller et soutenir la mission de l'entreprise pour développer des revêtements protecteurs de surface qui réduisent la propagation des agents pathogènes. L'expertise de Dr. Ramchandani, en particulier dans la réponse aux pandémies et la résistance aux antibiotiques, est en accord avec l'objectif de FendX de répondre aux menaces croissantes pour la santé publique. Sa nomination devrait contribuer de manière significative aux efforts de FendX pour créer des solutions révolutionnaires afin de réduire la transmission des agents pathogènes et d'améliorer le bien-être général.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) hat Dr. Rohit Ramchandani zum Berater ernannt, um seine umfangreiche Expertise im Bereich der öffentlichen Gesundheit für die Förderung innovativer Lösungen zur Kontrolle von Krankheitserregern und Sicherheit zu nutzen. Dr. Ramchandani, ein globaler Experte für öffentliche Gesundheit und Kontrolle von Infektionskrankheiten, bringt fast zwei Jahrzehnte Erfahrung in der Gestaltung, Implementierung und Skalierung innovativer Ansätze zur Krankheitsbekämpfung und Stärkung von Gesundheitssystemen mit.
Seine Rolle bei FendX besteht darin, die Mission des Unternehmens zu informieren, zu beraten und zu unterstützen, die darin besteht, schützende Beschichtungen für Oberflächen zu entwickeln, die die Verbreitung von Krankheitserregern verringern. Die Expertise von Dr. Ramchandani, insbesondere in Bezug auf die Reaktion auf Pandemien und Antibiotikaresistenzen, passt zu FendX' Ziel, wachsende Bedrohungen für die öffentliche Gesundheit anzugehen. Seine Ernennung wird voraussichtlich erheblich zu FendX' Bemühungen beitragen, bahnbrechende Lösungen zur Minderung der Übertragung von Krankheitserregern zu schaffen und das allgemeine Wohlbefinden zu verbessern.
- Appointment of a highly qualified public health expert as advisor
- Potential for leveraging Dr. Ramchandani's global network and expertise in infectious disease control
- Alignment with growing public health concerns, such as antibiotic resistance
- None.
Dr. Ramchandani is a global expert in public health, infectious disease control, and policy implementation.
He served as an advisor for the Independent Panel for Pandemic Preparedness and Response, developing recommendations for redesigning systems to improve future pandemic responses.
He has worked with various public health organizations including CDC, United Nations and other international organizations and governments on health systems and product innovations.
His role at Fendx will be to inform, advise, and support the Company in its mission to develop innovative surface protection products that reduce pathogen spread and enhance the health and well-being of people and their communities.
Oakville, Ontario--(Newsfile Corp. - July 31, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings to reduce the spread of pathogens, is pleased to announce the appointment of Dr. Rohit Ramchandani as an advisor to the Company, to provide his extensive public health expertise to further the Company's goal of advancing innovative solutions for pathogen control and safety.
Dr. Rohit Ramchandani, an accomplished public health professional with a global health background, brings a broad perspective and deep expertise in infectious disease control. The Company aims to leverage his extensive knowledge and global network to advance their mission of creating groundbreaking solutions that mitigate pathogen transmission and improve overall well-being. His expertise on pandemic response, including the recent COVID-19 pandemic, and the rising public health concerns of antibiotic resistance will be particularly valuable, especially in the context of surface contamination health risk and protection. A recent CDC report highlights a
Dr. Ramchandani, an expert researcher, educator, and implementation scientist, specializes in designing, implementing, evaluating, and scaling innovative approaches for disease control and health system strengthening. With nearly two decades of research and practice, his focus includes program evaluation, health policy, and disease prevention/treatment technologies. He has advised Fortune 500 companies, ministries of health, and international organizations across Africa, Asia, and the Americas. Dr. Ramchandani also served as an advisor to the Independent Panel for Pandemic Preparedness and Response, providing recommendations to curb the COVID-19 pandemic and prevent future outbreaks. His analysis on redesigning systems for pandemic response, including vaccine distribution and diagnostics, was published in the British Medical Journal, contributing insights to the world's first draft pandemic agreement.
His impactful work has garnered recognition from prominent media outlets such as the CBC, BBC, Business Week, Development Asia Magazine, and TED. His research has been published in peer-reviewed journals like the Lancet and British Medical Journal. As a public health leader, he and work he has led have received numerous prestigious awards, including the Financial Times/International Finance Corporation (FT/IFC) Transformational Business Award in Health and the London Design Museum's Product Design of the Year. Additionally, he is an alumnus of renowned programs, including the Governor General's Canadian Leadership Conference, The AKFC Global Leadership Program, and Shad Valley. His contributions have played a pivotal role in shaping global health policies and initiatives.
Dr. Carolyn Myers, CEO of FendX states, "We are pleased to welcome Dr. Ramchandani to our team and are excited to work with someone of his global public health caliber. His vast expertise in leveraging evidence-based solutions for complex health challenges aligns well with FendX's mission to reduce the spread of pathogens through developing products using our cutting-edge nanotechnology. His work in designing, evaluating, and scaling health innovations, coupled with his commitment to improving global health equity and controlling the spread of diseases, makes him a valuable addition to the FendX team."
Dr. Ramchandani holds a Doctor of Public Health degree from Johns Hopkins Bloomberg School of Public Health, a Masters in Public Health from Boston University, and a BSc from the University of Waterloo. He currently serves as Associate Faculty at the Johns Hopkins Bloomberg School of Public Health. Dr. Ramchandani also founded and is the CEO of Antara Global Health Advisors, a consulting firm which provides technical expertise in public health, including pandemic preparedness and response. In addition, Dr. Ramchandani recently completed his term servicing as a member of the Board of Directors of the Jane Goodall Institute of Canada.
About FendX Technologies Inc.
FendX is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has exclusive worldwide licenses to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.
ON BEHALF OF FENDX TECHNOLOGIES INC.
"Carolyn Myers"
Carolyn Myers
Chief Executive Officer and Director
Contacts:
Dr. Carolyn Myers, CEO and Director
1-800-344-9868
investor@fendxtech.com
For more information, please visit https://fendxtech.com/ and the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release
Forward-Looking Statements
This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; the Company's goal of advancing innovative solutions for pathogen control and safety and enhance the health and well-being of people and their communities; and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "aims," "potential," "goal," "objective," "prospective," and similar expressions, or that events or conditions "will," "would," "may," "can," "could" or "should" occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made and involve several risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and that actual results and future events could differ materially from those anticipated in such statements.
Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company's public filings which are available on SEDAR+ at www.sedarplus.ca. Accordingly, the reader is urged to refer to the Company's such filings for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors should change.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/218329
FAQ
Who is Dr. Rohit Ramchandani and what is his role at FendX Technologies (FDXTF)?
What experience does Dr. Ramchandani bring to FendX Technologies (FDXTF)?
How might Dr. Ramchandani's appointment impact FendX Technologies' (FDXTF) development of nanotechnology products?
What are the potential benefits of Dr. Ramchandani's global network for FendX Technologies (FDXTF)?
